Question 1

What are the potential side effects of the TNF treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma clinical trial (NCT00002262). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options I might have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma clinical trial (NCT00002262). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment process look like and how often will I need to come in?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma clinical trial (NCT00002262). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific health conditions that would prevent me from participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma clinical trial (NCT00002262). Contact the study team or your healthcare provider for specific answers.

Question 5

What kind of monitoring will be done during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma clinical trial (NCT00002262). Contact the study team or your healthcare provider for specific answers.

Question 6

How will we measure if the treatment is working for me?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma clinical trial (NCT00002262). Contact the study team or your healthcare provider for specific answers.

What this study is about